![Mir Morris Hosseini](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mir Morris Hosseini
Direktor/Vorstandsmitglied bei Tissue Regeneration Therapeutics, Inc.
Ursprung des Netzwerks ersten Grades von Mir Morris Hosseini
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Tissue Regeneration Therapeutics, Inc.
![]() Tissue Regeneration Therapeutics, Inc. BiotechnologyHealth Technology Tissue Regeneration Therapeutics, Inc. operates as a biotechnology company. It develops osteoscaf, a biodegradable and osteoconductive scaffold for use in healing tissue defects. The company is headquartered in Toronto, Canada.
2
| Holding Company | Biotechnology | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Mir Morris Hosseini
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
University of Toronto | College/University | Corporate Officer/Principal | |
American Society of Hematology
![]() American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | President | |
American Society for Blood & Marrow Transplantation | President | ||
Princess Margaret Hospital | Chief Tech/Sci/R&D Officer | ||
Pancella Therapeutics, Inc.
![]() Pancella Therapeutics, Inc. BiotechnologyHealth Technology Pancella Therapeutics, Inc. develops novel therapies for geno dermatoses. The company is headquartered in Toronto, Canada. | Biotechnology | Director/Board Member | |
panCELLa, Inc.
![]() panCELLa, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Pluristyx, Inc., panCELLa, Inc. is a privately held early-stage biotechnology firm based in Toronto, CA. panCELLa was acquired by Pluristyx, Inc. on October 06, 2022. panCELLa has secured partnerships with several biotechnology partners to enhance its patent position and provide expanded access to its exclusive failsafe™ and cloaked cells™/iact cells. The Canadian company continues its internal R & D efforts to develop additional novel uses of its platform technologies in areas such as bio-production, cancer vaccination, and tolerization. The company was founded in 2015 by Armand Keating and Andras Nagy, and has created platforms that allow for the development of safe, universal, cost-effective, “ off-the-shelf ” therapeutic cell products for medicine. | Miscellaneous Commercial Services | Founder | |
ROQUEFORT THERAPEUTICS PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistik
International
Kanada | 5 |
Vereinigte Staaten | 3 |
Vereinigtes Königreich | 2 |
Sektoral
Commercial Services | 3 |
Health Technology | 3 |
Consumer Services | 2 |
Operativ
Director/Board Member | 4 |
President | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Founder | 1 |
Corporate Officer/Principal | 1 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Armand Keating | 8 |
John Edward Davies | 1 |
- Börse
- Insiders
- Mir Morris Hosseini
- Unternehmensverbindungen